Yesterday the Food and Drug Administration (FDA) approved Spravato (esketamine) nasal spray to be us...
A subset of individuals 65 years or older with treatment-resistant depression who took a new oral an...
An independent advisory panel to the Food and Drug Administration (FDA) on Tuesday endorsed the eske...
Intranasal esketamine taken twice weekly can rapidly reduce symptoms of people with treatment-resist...
